Table 3 Multivariate analysis of three clinical outcomes of PVT in the internal cohort

Gastrointestinal bleeding events

 History of GIB

0.77

3.42

2.16(0.96,4.88)

0.0645

 SMV thrombosis

0.27

0.53

1.31(0.63,2.73)

0.4675

 Red color sign

0.80

3.92

2.22(1.01,4.90)

0.0478

 Hepatic encephalopathy

0.38

0.69

1.46(0.60,3.55)

0.4068

Portal vein thrombus resolution events

 History of abdominal infection

-0.62

7.28

0.54(0.35,0.85)

0.0070

 HB ≥ 115(g/L)

0.63

7.50

1.88(1.20,2.96)

0.0062

 CRP > 5(mg/L)

-0.86

13.91

0.42(0.27,0.67)

0.0002

 Anticoagulant therapy

1.03

17.31

2.81(1.73,4.56)

 < 0.0001

 Antiplatelet therapy

0.20

0.31

1.22(0.60,2.48)

0.5755

Death events

 Abdominal infection

0.64

4.48

1.89(1.05,3.41)

0.0343

 Abdominal surgery

0.40

1.83

1.51(0.83,2.69)

0.1764

 AST > 35 (U/L)

0.80

7.57

2.23(1.26,3.96)

0.0059

 Hepatic encephalopathy

0.25

0.12

0.78(0.19,3.27)

0.7323

 Ascite

0.67

5.02

1.95(1.09,3.51)

0.0251